The reasons behind Big Data's rise

Fiscal concerns are paramount in the rise of Big Data within healthcare, according to a recent McKinsey analysis, but clinical trends also play a role.

Healthcare expenses are now 17.6% of GDP—nearly $600 billion more than the expected benchmark for a nation of the United States's size and wealth, notes the consultancy, which did a regression analysis of countries' income and spending data.

Payors are seeking to clamp costs by shifting from fee-for-service compensation to risk-sharing arrangements that prioritize outcomes, as well as partnering with pharma and basing reimbursement on drugs' ability to improve health. McKinsey also cites the move toward evidence-based medicine, with its reliance on aggregating individual data sets into big-data algorithms.

Healthcare could soon catch up to other sectors in using Big Data, as first movers in the data sphere are already achieving positive results.
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.